Introduction {#s1}
============

Type 2 diabetes (T2D) is a disease epidemic characterized by hyperglycemia in the context of insulin resistance. During the pathogenesis of T2D, insulin resistance pressures pancreatic β-cells to compensate by increasing insulin production. Unfortunately, one-third of insulin-resistant individuals develop β-cell failure and lose β-cell mass, therefore requiring insulin replacement therapy. Although extensively studied, the mechanisms leading to β-cell failure are poorly understood; however, several factors identified include genetic predisposition, hyperglycemia, hyperlipidemia, and inflammatory cytokines ([@B1]). Recent studies suggest that increased proinsulin synthesis overwhelms the capacity of the endoplasmic reticulum (ER) to properly fold, process, and secrete insulin ([@B1],[@B2]). Under these conditions, termed ER stress, cells activate the adaptive unfolded protein response (UPR) to resolve the protein-folding defect. Increased expression of UPR genes is observed in islets from humans with T2D ([@B3],[@B4]); therefore it was proposed that the UPR is activated in β-cells in response to insulin resistance as part of a compensatory mechanism to increase insulin production ([@B5],[@B6]).

The UPR signals through three ER-localized transmembrane sensors, the double stranded RNA--activated protein kinase--like ER kinase (PERK), the inositol-requiring protein 1α, and the activating transcription factor 6α ([@B7],[@B8]). When misfolded proteins accumulate, PERK phosphorylates the α-subunit of eukaryotic translation initiation factor 2 (eIF2α) to attenuate mRNA translation and reduce the protein-folding load. Paradoxically, eIF2α phosphorylation is required for translation of selective mRNAs, including activating transcription factor 4. However, if the UPR adaptive response is not sufficient to resolve the protein-folding defect, cells initiate apoptotic cell death, in part through induction of the proapoptotic gene *Chop*/*Gadd153* ([@B9]).

Previous studies demonstrated a requirement for UPR signaling in β-cell function. Deletion of *Xbp1* in mice or *Perk* in humans and mice causes β-cell failure ([@B10]--[@B13]). Notably, mice with a β-cell-specific Ser51 to Ala mutation at the PERK phosphorylation site in eIF2α also develop β-cell failure, similar to *Perk* deletion ([@B14]). The Ser51Ala eIF2α mutation releases the brake on mRNA translation, thereby increasing proinsulin synthesis in β-cells to cause accumulation of misfolded proinsulin in the ER, loss of insulin secretory granules, oxidative stress, and β-cell apoptosis ([@B15],[@B16]). Importantly, these findings provide evidence that a modest increase in proinsulin synthesis (∼30%), similar to that which may occur in the insulin-resistant state but in the absence of hyperglycemia, hyperlipidemia, and inflammatory cytokines, is sufficient to initiate all the characteristics of β-cell failure observed in T2D. Because increased protein synthesis would also challenge the protein folding machinery in the ER of the β-cell, we analyzed whether protein misfolding in the ER causes oxidative stress.

Mechanistically, the regulation of proinsulin synthesis, folding, and processing in the β-cell is largely unknown. The most abundant molecular chaperone in the ER is a DnaK family member, the peptide-dependent ATPase glucose-regulated protein (GRP)78/BiP. P58^IPK^/DNAJc3 is a DnaJ family member that acts as a co-chaperone for GRP78 by promoting peptide binding and stimulating the GRP78 ATPase activity ([@B17]--[@B19]). P58^IPK^ expression is increased in islets from individuals with T2D ([@B4]). *P58^IPK^* deletion causes a mild protein-folding defect in the ER in mouse embryonic fibroblasts ([@B17],[@B18]). *P58^IPK^* deletion does not, however, cause a significant phenotype other than eventual β-cell failure with glucose intolerance ([@B20],[@B21]). Here we show that the protein-folding defect in *P58^IPK^*^−/−^ mice reduces β-cell mass and function that is associated with activation of the proapoptotic UPR and increased levels of oxidative stress. In addition, either deletion of *Chop* or treatments with chemical chaperones or antioxidants dramatically preserve β-cell mass and function in *P58^IPK−/−^* mice. The results identify three different interventions that preserve β-cells with defective chaperone function that may have relevance to therapy for T2D in humans.

Research Design and Methods {#s2}
===========================

Mice {#s3}
----

*P58^IPK−/−^* mice were backcrossed eight times into *C57BL/6J* mice (The Jackson Laboratory). *P58^IPK−/−^* mice were bred with *Chop^−/−^* mice in a *C57BL/6J* background. *RIP1-Tag2* mice ([@B22]) were obtained from the National Cancer Institute. Studies were performed with littermate male mice that were housed with 12-h light/12-h dark cycles with free access to water and standard rodent chow (Laboratory Rodent Diet 5001; LabDiet). Chow supplemented with butylated hydroxyanisole (BHA; Sigma-Aldrich) was formulated by Research Diets Inc. (0.7% BHA in a base of Laboratory Rodent Diet 5001). Male mice were housed pairwise for the diet studies. 4-Phenylbutyric acid (PBA; Calbiochem) was administered through intraperitoneal injection. All animal care and procedures were conducted according to the protocols and guidelines approved by the University of Michigan Committee on the Use and Care of Animals or the Sanford-Burnham Medical Research Institute Institutional Animal Care and Use Committee. Blood glucose, glucose tolerance test (GTT), and insulin tolerance test measurements were performed as described previously ([@B23]).

Islet Isolation and Glucose-Stimulated Insulin Secretion {#s4}
--------------------------------------------------------

Islets were isolated by intraductal collagenase P (Roche) perfusion, histopaque-1077 gradient (Sigma-Aldrich) purification, and hand picking ([@B16]). Glucose-stimulated insulin secretion (GSIS) was performed as described previously ([@B23]).

Generation of β-Cell Lines and Cell Culture {#s5}
-------------------------------------------

*RIP1-Tag2* mice were crossed with *P58^IPK−/−^* mice to generate heterozygous F1 mice, which were intercrossed to obtain *RIP1-Tag2;P58^IPK−/−^* or *RIP1-Tag2;P58^IPK+/+^* mice. Islet tumors were excised and subjected to collagenase digestion, yielding *P58^IPK+/+^* and *P58^IPK−/−^* mouse insulinoma (MI) cells. Established MI cell lines and INS1 cells were maintained in RPMI 1640 medium (11 mmol/L glucose) supplemented with 10% FBS, 2 mmol/L sodium pyruvate, 50 μmol/L β-mercaptoethanol, and penicillin/streptomycin. MIN6 cells were maintained in DMEM (27.5 mmol/L glucose) supplemented with 15% FBS and penicillin/streptomycin. A replication-defective adenovirus expressing *Akita* mutant proinsulin was generated using established protocols (Ad-Easy system; Stratagene) and was used with adenovirus encoding β-galactosidase (β-gal) as the control. MI cells were infected with adenoviruses for 24 h at 100 multiplicity of infection.

Islet Morphology and Immunohistochemistry {#s6}
-----------------------------------------

Pancreata were isolated, fixed with 10% buffered formalin, and embedded in paraffin. Sections were prepared and either stained with hematoxylin and eosin for visualization of islet morphology by light microscopy or subjected to immunohistochemistry. Nitrated proteins were detected with anti-nitrotyrosine antibody (Upstate) using the Histostatin-Plus Kit (Zymed Laboratories). Anti-insulin (1:200; Linco, 4011--01) and anti-glucagon (1:200; Linco, 4030--01F) antibodies were identified with anti--guinea pig Texas red (1:1000; Jackson ImmunoResearch, 106--075--003,) and with goat anti-rabbit Alexa Fluor 488 as the secondary antibody (1:1000; Invitrogen, A11008), respectively. Anti-PDX1 (1:200; Millipore, 07--696) and anti-4-hydroxynonenal (1:200; Abcam, ab46545) antibodies were identified with antirabbit Alexa Fluor 594 as the secondary antibody (1:1000; Invitrogen, A11037). Anti-MafA (1:100; Santa Cruz Biotechnology, sc-27140) antibody was identified with anti-goat Alexa Fluor 594 as the secondary antibody (1:1000; Invitrogen, A11058). In [Fig. 6*F*](#F6){ref-type="fig"}, anti-proinsulin (1:200; HyTest Ltd., 2PR8) antibody was identified with anti-mouse Alexa Fluor 594 (1:1000; Invitrogen, A11005). In [Fig. 7*C*](#F7){ref-type="fig"} and [Supplementary Fig. 8](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1), anti-insulin antibodies was identified with anti--guinea pig Alexa Fluor 488 (1:1000; Invitrogen, A11073).

Islet Mass Measurement {#s7}
----------------------

For islet mass measurements, the entire pancreas was serially sectioned into 5-μm samples collected at 50-μm increments. We then chose 25--40 slides spanning each pancreas for hematoxylin and eosin histochemistry. Images covering the entire tissue sample were subsequently captured using an EVOS microscope (Invitrogen). The entire pancreas tissue area and islet area in each image were measured using ImageJ software (National Institutes of Health, Bethesda, MD). Relative islet mass (percentage) was defined as the sum of the islet area measured in all the images from each mouse divided by the sum of the total pancreas tissue area measured in all the images from each mouse, times 100. This technique was applied to *1*) the *P58^IPK−/−^* and *P58^IPK+/+^* mice at 16--20 weeks of age (*n* = 3 mice per group) ([Fig. 1](#F1){ref-type="fig"}); *2*) *P58^IPK−/−^Chop^+/−^* and *P58^IPK−/−^Chop^−/−^* at 16 weeks of age (*n* = 4 mice per group) ([Fig. 3](#F3){ref-type="fig"}); *3*) *P58^IPK−/−^*mice at 16--20 weeks of age were subsequently fed with control or BHA-supplemented chow for 6 weeks (*n* = 4 mice per group) ([Fig. 4](#F4){ref-type="fig"}).

![Deletion of *P58^IPK^* in mice causes β-cell failure. *A*: Blood glucose was measured in *P58^IPK+/+^* and *P58^IPK−/−^* mice at the indicated age after a 5-h fast (*n* = 5 or 6 mice per group). *B*: A GTT was performed (*n* = 5 or 6 mice \[6--7 weeks of age\] per group). *C*: An insulin tolerance test was performed (*n* = 5 or 6 mice \[9--10 weeks of age\] per group). *D*: Serum insulin after a 5-h fast was measured in 16- to 20-week-old mice after a 5-h fast. *E*: Western blot analysis was performed using 100 islets isolated from 10-week-old mice. *F*: Pancreatic insulin content was measured and normalized to protein content (*n* = 5 mice \[10--12 weeks of age\] per group). *G*: Islet mass was measured in pancreatic sections from 16- to 20-week-old mice. The percentage indicates the total islet mass over the pancreas area in each pancreata (*n* = 3 mice per group). *H*: Immunohistochemistry for insulin and glucagon was performed on pancreatic sections from 10- to 12-week-old mice. Representative images are shown. Scale bar represents 100 μm. *I*: Transmission electron microscopy was performed on pancreatic sections from 12-week-old mice. Representative images are shown. Scale bar represents 2 μm in upper panels and 0.5 μm in lower panels. ER, rough endoplasmic reticulum; M, mitochondria. \**P* \< 0.05; \*\**P* \< 0.01.](db141357f1){#F1}

Insulin and Hydroxyoctadecadienoic Acid Measurements {#s8}
----------------------------------------------------

Pancreata were homogenized in a cold solution of acid/ethanol containing 75% ethanol and 0.18 mol/L hydrochloric acid, followed by overnight incubation at 4°C. The extracts then were centrifuged, and supernatants were diluted into sample buffer. Insulin was measured by ELISA (ALPCO). Lipid peroxidation (hydroxyoctadecadienoic acids \[HODEs\]) was measured as previously described ([@B16]).

Cell Viability Assays {#s9}
---------------------

Relative cell viabilities were measured using Cell Counting Kit-8 (Dojindo, Rockville, MD) according to the manufacturer's instructions.

Gene Expression Studies {#s10}
-----------------------

Total RNA was extracted from cells or islets (at least 50) using RNAeasy (Qiagen). The relative amounts of mRNAs were measured by quantitative real-time PCR with SYBR green (Bio-Rad). Real-time primer sequences are shown in [Supplementary Table 1](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1).

Western Blot Analyses {#s11}
---------------------

Cells were collected in cell lysis buffer (50 mmol/L Tris-HCl \[pH 7.4\], 150 mmol/L NaCl, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate and protease inhibitors \[Roche\]). Primary antibodies were as follows: anti-PARP (1:1000; Cell Signaling Technology, 9542), anti-tubulin (1:5000; Sigma-Aldrich, T5168), anti-CHOP (1:200; Santa Cruz Biotechnology, sc-575), and anti-KDEL (1:1000; Abcam, ab12223), anti-insulin (1:1000; Sigma-Aldrich, I2018), and anti-proinsulin (1:1000; HyTest Ltd., 2PR8). Anti-P58^IPK^ antibody was obtained from one of the authors (M.G.K.). Anti-rabbit antibody conjugated with horseradish peroxidase (1:5000; Millipore, AQ132P) for CHOP and PARP, and anti-mouse antibody (1:5000; Millipore, AP192P) for tubulin, KDEL, insulin, and proinsulin, were used as secondary antibodies.

Transmission Electron Microscopy {#s12}
--------------------------------

Transmission electron microscopy was performed on pancreas tissue as previously described ([@B16]).

Statistical Analysis {#s13}
--------------------

Data are presented as means ± SEMs. The statistical significance of differences between groups was evaluated using the Student *t* test. *P* values \<0.05 were considered statistically significant.

Results {#s14}
=======

*P58^IPK−/−^* Mice Develop Diabetes as a Result of Pancreatic β-Cell Failure Associated With Oxidative Stress {#s15}
-------------------------------------------------------------------------------------------------------------

To investigate the effect of *P58^IPK^* deletion on β-cell physiology, we first analyzed blood glucose concentrations (BGCs) and body weight of *P58^IPK+/+^* and *P58^IPK−/−^* male mice fed a regular diet ([Fig. 1*A*](#F1){ref-type="fig"} and [Supplementary Fig. 1*A*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). After 10 weeks of age, the fasting BGC in *P58^IPK−/−^* mice steadily increased and became significantly greater after 21 weeks of age compared with that of *P58^IPK+/+^* mice, consistent with earlier observations ([@B20]). Although there was no significant difference in fasting BGCs between genotypes at 10--14 weeks, the *P58^IPK−/−^* mice were glucose intolerant as early as 6--7 weeks ([Fig. 1*B*](#F1){ref-type="fig"}). Interestingly, there was no significant difference in islet morphology or mass 1 day after birth, indicating that the loss of β-cell mass and/or function starts after birth and likely does not originate from a developmental defect ([Supplementary Fig. 1*B*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). There were, however, no significant differences in insulin sensitivity ([Fig. 1*C*](#F1){ref-type="fig"}) or liver morphology ([Supplementary Fig. 1*C*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)) between genotypes.

Hyperglycemia in the *P58^IPK−/−^* mice correlated with reduced serum ([Fig. 1*D*](#F1){ref-type="fig"}) and pancreatic insulin contents ([Fig. 1*E* and *F*](#F1){ref-type="fig"}) and decreased islet size and mass ([Fig. 1*G* and *H*](#F1){ref-type="fig"} and [Supplementary Fig. 1*D*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). Transmission electron microscopy demonstrated β-cells from *P58^IPK−/−^* mice had a marked decrease in insulin granules and a distended ER, indicating that *P58^IPK−/−^* β-cells experience ER stress ([Fig. 1*I*](#F1){ref-type="fig"}). Although the number of mitochondria was not significantly different between genotypes ([Supplementary Fig. 1*E*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)), mitochondria in *P58^IPK−/−^* cells were more swollen, suggesting mitochondrial damage ([Fig. 1*I*](#F1){ref-type="fig"}). The ER luminal distension and mitochondrial swelling in *P58^IPK−/−^* β-cells suggested the β-cells experience ER stress and oxidative stress ([@B16]). Indeed, a specific antibody against nitrotyrosine, a product of tyrosine nitration mediated by reactive nitrogen species, intensively stained islets from *P58^IPK−/−^* mice compared with islets from *P58^IPK+/+^* mice ([Fig. 2*A*](#F2){ref-type="fig"}). In addition, lipid peroxidation (HODE) was significantly greater in islets from *P58^IPK−/−^* mice ([Fig. 2*B*](#F2){ref-type="fig"}), indicating oxidative stress.

![Deletion of *P58^IPK^* causes oxidative stress in β-cells. *A*: Immunohistochemistry for nitrotyrosine was performed on pancreatic sections from 12-week-old mice. Representative images are shown. Scale bar represents 100 μm. *B*: HODEs were measured in extracts from 50 islets isolated from 10- to 12-week-old mice (*n* = 6 mice per group). *C*: Quantitative RT-PCR was performed using total RNA extracted from islets from *P58^IPK+/+^* and *P58^IPK−/−^* mice at 4, 6--7, or 10 weeks of age (*n* = 3--6 mice per group). All data are mean ± SEM. *\*P \<*0.05;*\*\*P*\< 0.01.](db141357f2){#F2}

To provide insight into the mechanism of β-cell failure in the absence of P58^IPK^, we analyzed gene expression in islets from mice at the age of 4 and 6--7 weeks. The expression of the β-cell-specific genes *Pdx1* and *MafA1* and their downstream transcriptional targets *Ins1*, *Ins2*, and *Glut2* was comparable at 4 weeks; however, their expression was significantly reduced at 6--7 weeks in *P58^IPK−/−^* islets ([Fig. 2*C*](#F2){ref-type="fig"}). Importantly, expression of *Hmox1* and *Gpx1* genes was increased at 4 weeks, whereas expression of *Cat*, *Hmox1*, *Gpx1*, *Gpx2*, *Sod1*, and *Sod2* was significantly decreased in *P58^IPK−/−^* islets ([Fig. 2*C*](#F2){ref-type="fig"}), suggesting oxidative stress occurs at 4 weeks in *P58^IPK−/−^* islets. It is noteworthy that the expression of cell death genes was increased at 6--7 weeks and further increased at 10 weeks of age in *P58^IPK−/−^* islets. In addition, the expression of UPR-related genes was significantly increased at 4 weeks in *P58^IPK−/−^* islets compared with *P58^IPK+/+^* islets, indicating the presence of ER stress at this age ([Fig. 2*C*](#F2){ref-type="fig"}).

*P58^IPK^* Deletion in β-Cells Increases Susceptibility to ER Stress--Induced Apoptosis {#s16}
---------------------------------------------------------------------------------------

To investigate the role of the UPR in β-cell failure associated with *P58^IPK^* deletion, we generated SV40 T antigen-immortalized β-cell lines from *P58^IPK−/−^* and *P58^IPK+/+^* mice. The expression of β-cell-specific genes in these lines was comparable to that in the well-characterized mouse insulinoma cell line MIN6 ([Supplementary Fig. 2](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)), indicating these cell lines represent a reasonable in vitro system to investigate β-cell physiology. In response to ER stress induced by tunicamycin (Tm), which inhibits N-linked glycosylation, the expression of the β-cell-specific genes *MafA*, *Pdx1*, *Ins1*, *Ins2*, and *Glut2* was greatly decreased in *P58^IPK−/−^* insulinoma cells compared with *P58^IPK+/+^* insulinoma cells, possibly suggesting dedifferentiation and/or dysfunction ([@B24]) ([Fig. 3*A*](#F3){ref-type="fig"}). In addition, Tm induction of the proapoptotic genes *P53*, *Tnfrsf10b*, *Tnfr*, and *Noxa* ([Fig. 3*B*](#F3){ref-type="fig"}), as well as the ER stress--induced proapoptotic genes *Atf3* and *Chop*, was significantly greater in *P58^IPK−/−^* cells compared with *P58^IPK+/+^* cells ([Fig. 3*C*](#F3){ref-type="fig"}). Indeed, the viability of *P58^IPK−/−^* β-cells was significantly reduced compared with *P58^IPK+/+^* cells in response to ER stress (Tm and thapsigargin) as well as oxidative stress (H~2~O~2~), with increased CHOP expression and PARP cleavage ([Fig. 3*D* and *E*](#F3){ref-type="fig"}). Notably, CHOP expression peaked ∼8 h after Tm treatment in both cell lines, but CHOP expression was sustained in *P58^IPK−/−^* cells; this correlated with increased PARP cleavage 24 h after Tm treatment ([Fig. 3*F*](#F3){ref-type="fig"}). This is consistent with a requirement for attenuated CHOP expression to survive ER stress ([@B25]).

![*P58^IPK^*^−/−^ β-cells are more susceptible to ER stress. *A--C*: Quantitative RT-PCR was performed using total RNA extracted from *P58^IPK+/+^* and *P58^IPK−/−^* β-cell lines treated with Tm (2 μg/mL) for 0, 8, or 24 h: pancreatic β-cell-specific genes (*A*); cell death genes (*B*); and UPR genes (*C*). *D*: Cell viability was measured in *P58^IPK+/+^* and *P58^IPK−/−^* β-cell lines treated with vehicle (Veh) (DMSO), Tm (2 μg/mL), or thapsigargin (Tg; 300 nmol/L) for 24 h and 0.6 mmol/L H~2~O~2~ for 8 h. *E*: Western blot analysis was performed using *P58^IPK+/+^* and *P58^IPK−/−^* β-cell lines treated with vehicle (DMSO), Tg (300 nmol/L), and Tm (2 μg/mL) for 24 h. *F*: Western blot analysis was performed using *P58^IPK+/+^* and *P58^IPK−/−^* β-cell lines treated with Tm (2 μg/mL) for 24 h. Cell lysates were harvested at the indicated time points. *G* and *H*: *P58^IPK+/+^* and *P58^IPK−/−^* β-cell lines were infected with adenovirus-expressing β-gal (rAd-β-gal) or *Akita* proinsulin (rAd-Akita) for 24 h. *G*: Total RNA was isolated for quantitative RT-PCR. *H*: Cell viability was measured. All data are mean ± SEM of three independent experiments. *\*P* \< 0.05; *\*\*P*\< 0.01. hr, hours.](db141357f3){#F3}

To test whether *P58^IPK−/−^* β-cells are more susceptible to physiological conditions of ER stress, we expressed the insulin 2 *Akita* mutant containing a Cys96Tyr mutation in the A chain ([@B26]), which is known to misfold and cause ER stress--mediated β-cell death ([@B27]). Upon *Akita* mutant expression in the β-cell lines, induction of *Chop* and *Atf3* was significantly greater in the *P58^IPK−/−^* β-cells ([Fig. 3*G*](#F3){ref-type="fig"}), and this correlated with reduced viability ([Fig. 3*H*](#F3){ref-type="fig"}). These results show that *P58^IPK−/−^* β-cells exhibit increased susceptibility to ER stress--mediated cell death, possibly associated with increased expression of CHOP.

Either Chemical Chaperone Treatment or *Chop* Deletion Prevents β-Cell Failure in *P58^IPK−/−^* Mice {#s17}
----------------------------------------------------------------------------------------------------

To test whether ER stress causes the β-cell failure observed in *P58^IPK−/−^* mice, we treated *P58^IPK−/−^* mice with the chemical chaperone 4-PBA, which relieves ER stress ([@B28]--[@B30]). Six weeks after PBA treatment, fasting hyperglycemia ([Fig. 4*A*](#F4){ref-type="fig"}) and glucose intolerance ([Fig. 4*B*](#F4){ref-type="fig"}) were reduced, suggesting that the *P58^IPK−/−^* β-cell failure results from protein misfolding in the ER, consistent with a defect in chaperone function. The results support the notion that a chemical chaperone can complement the requirement for protein chaperone function to preserve β-cell function.

![Chemical chaperone treatment preserves β-cell function in *P58^IPK−/−^* mice. *P58^IPK+/+^* and *P58^IPK−/−^* mice aged 22--26 weeks were treated intraperitoneally with saline or PBA (500 mg/kg body weight/day) for the indicated durations. Blood glucose was measured after a 5-h fast (*A*) and GTTs were performed before and after treatment with PBA for 42 days (*B*) (*n* = 4 or 5 mice per group). Significant differences between *P58^IPK−/−^* mice treated with saline or PBA are shown. *\*P*\< 0.05;*\*\*P*\< 0.01. Significance was shown between *P58^IPK−/−^* and *P58^IPK−/−^* with PBA treatment.](db141357f4){#F4}

Previous studies demonstrated that *Chop* deletion protects β-cells in models of T2D and in *Akita* mice, which express a folding-defective mutant proinsulin ([@B23],[@B27]). In particular, studies suggested that CHOP is required for oxidative stress that occurs in response to ER stress ([@B23],[@B31]--[@B33]). In addition, we demonstrated that CHOP expression was significantly greater in *P58^IPK−/−^* cells compared with *P58^IPK+/+^* cells. Therefore we investigated the requirement for CHOP in the cell death observed in *P58^IPK^*^−/−^ β-cells. *P58^IPK−/−^* mice were crossed with *Chop^−/−^* mice to generate *P58^IPK−/−^Chop^−/−^* mice. At 16 weeks of age, *Chop* deletion reduced hyperglycemia, which was sustained up to 41 weeks of age ([Fig. 5*A*](#F5){ref-type="fig"}). Significantly improved glucose tolerance was observed at 16 weeks of age, which was more prominent at 36 weeks of age ([Fig. 5*B*](#F5){ref-type="fig"}). *P58^IPK−/−^Chop^−/−^* mice maintained postprandial BGCs within the normal range and increased insulin secretion upon fasting and refeeding ([Supplementary Fig. 3*A* and *B*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). The improved glucose homeostasis in *P58^IPK−/−^Chop^−/−^* mice was associated with increased insulin content ([Fig. 5*C*](#F5){ref-type="fig"}) and islet mass ([Fig. 5*D*](#F5){ref-type="fig"} and [Supplementary Fig. 3*C*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). Strikingly, *Chop* deletion preserved intracellular organelle integrity and insulin granule content in the *P58^IPK−/−^* β-cells ([Fig. 5*E*](#F5){ref-type="fig"}). These results demonstrate that *Chop* deletion protects β-cells from ER stress caused by the deletion of a protein chaperone in the ER.

![*Chop* deletion preserves β-cell function in *P58^IPK−/−^* mice. *A*: Blood glucose was measured at the indicated times, either ad libitum or after a 5-h fast, in mice with the indicated genotypes up to 41 weeks of age (*n* = 7--13 mice per group). *B*: GTTs were performed in mice with the indicated genotypes. Glucose doses were 2 mg/kg body weight for mice 14 and 16 weeks of age and 1 mg/kg body weight for mice 36 weeks of age (*n* = 7--13 mice per group). Significance was shown between *P58^IPK−/−^ Chop^+/−^* and *P58^IPK−/−^ Chop^−/−^*. *C*: Pancreatic insulin was measured in mice with the indicated genotypes at 16 weeks of age (*n* = 4--6 mice per group). *D*: Islet mass was measured in pancreatic sections from 16-week-old *P58^IPK−/−^ Chop^+/−^* or *P58^IPK−/−^ Chop^−/−^* mice and their littermates. The percentage indicates the total islet mass over the pancreas area in each pancreata (*n* = 4 mice per group). *E*: Transmission electron microscopy was performed on pancreatic sections from *P58^IPK+/−^Chop^+/−^* mice and *P58^IPK−/−^Chop^−/−^* mice at 38--41 weeks of age. Representative images are shown. Scale bar represents 0.5 μm. All data are mean ± SEM. *\*P \<*0.05;*\*\*P \<*0.01.](db141357f5){#F5}

Antioxidant Treatment Restores β-Cell Function in *P58^IPK−/−^* Mice and *Akita* Mice {#s18}
-------------------------------------------------------------------------------------

The oxidative damage observed in *P58^IPK−/−^* islets ([Fig. 2](#F2){ref-type="fig"}), as well as the previously suggested relationship between protein misfolding in the ER and reactive oxygen species (ROS) production ([@B34]), prompted us to assess the contribution of oxidative stress to β-cell failure by analyzing the effect of the antioxidants BHA, sodium 4,5-dihydroxybenzene-1,3-disulfonate (Tiron), 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL), and manganese \[III\] tetrakis (4-benzoic acid) porphyrin (MnTBAP). Among these treatments, Tiron ([Supplementary Fig. 4](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)) and MnTBAP ([Supplementary Fig. 5](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)) did not alter the abnormal BGCs or GTT results in *P58^IPK−/−^* mice, whereas treatment with TEMPOL improved the GTT results in *P58^IPK−/−^* mice after 42 days ([Supplementary Fig. 6](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). Of all these treatments, feeding *P58^IPK−/−^* mice with a BHA-supplemented diet for as little as 1 week normalized the BGCs after ad libitum feeding and short fasts; these were maintained up to 38 weeks ([Fig. 6*A*](#F6){ref-type="fig"}), with no significant difference in body weight ([Supplementary Fig. 7*A*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). Strikingly, 2 weeks after feeding of the BHA-supplemented diet, the GTT results were completely normalized in the *P58^IPK−/−^* mice compared with *P58^IPK+/+^* mice ([Fig. 6*B*](#F6){ref-type="fig"}), with no significant difference in insulin sensitivity ([Supplementary Fig. 7*B*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). The normalized GTT result was maintained with up to 40 weeks of feeding of the BHA-supplemented diet ([Fig. 6*B*](#F6){ref-type="fig"}). In addition, feeding BHA-supplemented chow to *P58^IPK−/−^* mice also improved blood glucose homeostasis and insulin secretion upon fasting and subsequent refeeding ([Supplementary Fig. 7*C* and *D*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). The increased insulin secretion correlated with increased insulin content ([Fig. 6*C*](#F6){ref-type="fig"}) and islet mass ([Fig. 6*D*](#F6){ref-type="fig"} and [Supplementary Fig. 7*E*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). The improved β-cell function also was observed by GSIS assays using islets isolated from mice that were fed with or without BHA-supplemented chow ([Fig. 6*E*](#F6){ref-type="fig"}). Immunofluorescence microscopy demonstrated BHA-supplemented chow increased insulin and proinsulin content in the *P58^IPK−/−^* mice ([Fig. 6*F*](#F6){ref-type="fig"}). Because deletion of *P58^IPK^* was engineered with insertion of a green fluorescent protein cassette, green fluorescent protein fluorescence is observed in acinar cells, although it is not detectably expressed in the islets. In addition, feeding *P58^IPK−/−^* mice with BHA-supplemented chow preserved organelle integrity and insulin granule content ([Fig. 6*G*](#F6){ref-type="fig"}). BHA feeding reduced oxidative damage in *P58^IPK−/−^* islets, as indicated by significantly reduced HODE concentrations, an indication of oxidative stress, in the islets from mice fed BHA-supplemented chow ([Fig. 7*A*](#F7){ref-type="fig"}). In addition, feeding *P58^IPK−/−^* mice with BHA-supplemented chow for 6 weeks significantly reduced the nuclear localization of the lipid peroxidation product 4-hydroxynonenal (HNE) ([Fig. 7*B*](#F7){ref-type="fig"}). 4-HNE was previously noted for nuclear localization under conditions of oxidative stress ([@B35],[@B36]). The reduced nuclear localization of 4-HNE suggests decreased oxidative damage in *P58^IPK−/−^* islets fed BHA-supplemented chow. The disappearance of MafA, but not PDX1, from the nucleus was previously associated with oxidative stress--mediated β-cell dysfunction ([@B37]); therefore we analyzed the localization of MafA and PDX1 in the islets. Nuclear localization of MafA, but not PDX1, was diminished in islets from *P58^IPK−/−^* mice and was restored in islets from *P58^IPK−/−^* mice fed BHA-supplemented chow ([Fig. 7*C*](#F7){ref-type="fig"} and [Supplementary Fig. 8](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1)). These results demonstrate that feeding of BHA-supplemented chow not only preserves but also restores β-cell function and mass in islets of *P58^IPK−/−^* mice by reducing oxidative stress.

![Antioxidant treatment prevents β-cell failure in *P58^IPK−/−^* mice. *A* and *B*: Mice with the indicated genotypes at 20--22 weeks of age were fed control chow or chow supplemented with BHA for up to 39 weeks (*n* = 3 or 4 mice per group). *A*: Blood glucose was measured either ad libitum or after a 5-h short fast. *B*: GTTs were performed on mice with the indicated genotypes before and 2 and 40 weeks after feeding with control or BHA-supplemented chow (*n* = 5--7 mice per group). Significance was shown between *P58^IPK−/−^* mice fed with control or BHA-supplemented chow. *C*: Pancreatic insulin contents were measured in mice fed control or BHA-supplemented chow for 40 weeks (*n* = 5 or 6 mice per group). *D*: Islet mass was measured in pancreatic sections from 16- to 20-week-old *P58^IPK−/−^* mice fed control or BHA-supplemented chow for 6 weeks. The percentage indicates the total islet mass over the pancreas area in each pancreata (*n* = 4 mice per group). *E*: GSIS (left panel) and insulin contents in total islet lysates (right panel) were measured in mice with the indicated genotypes fed control chow or BHA-supplemented chow for 40 weeks. Islets from two animals per condition were analyzed in triplicate. *F*: Insulin and proinsulin immunohistochemistry was performed on pancreatic sections from *P58^IPK+/+^* and *P58^IPK−/−^* mice fed control or BHA-supplemented chow for 40 weeks. Representative images are shown. Scale bars represent 30 μm. *G*: Transmission electron microscopy was performed on pancreatic sections from *P58^IPK−/−^* mice fed control or BHA-supplemented chow for 22 weeks. Representative images are shown. Scale bar represents 0.5 μm. \**P* \< 0.05; \*\**P* \< 0.01.](db141357f6){#F6}

![Antioxidant feeding improves β-cell function in *P58^IPK−/−^* mice. *A*: HODEs were measured in extracts from 50 islets isolated from mice aged 7--9 weeks that were fed control chow or BHA-supplemented chow for 3 weeks (*n* = 5--7 mice per group). *B*: Immunohistochemistry for 4-HNE was performed on pancreatic sections from *P58^IPK−/−^* mice fed control chow or BHA-supplemented chow for 6 weeks. Representative images are shown. Arrows indicate nuclei. Scale bar represents 100 μm. *C*: Immunohistochemistry for MafA and insulin was performed on pancreatic sections from *P58^IPK+/+^* or *P58^IPK−/−^* mice fed control or BHA-supplemented chow for 6 weeks. Representative images are shown. Scale bar represents 100 μm. All data are mean ± SEM. \*\**P* \< 0.01.](db141357f7){#F7}

The dramatic effect of BHA feeding on preserving β-cell function in *P58^IPK−/−^* mice prompted us to test its potential to improve β-cell function in a more severe model of ER protein misfolding in the β-cell using the *Akita* mouse, which has a Cys96Tyr mutation in the insulin gene; this mutation disrupts disulfide bond formation, resulting in misfolded proinsulin and oxidative stress in β-cells ([@B38]). Indeed, BHA feeding improved glucose homeostasis in heterozygous *Akita* mice ([Fig. 8*A* and *B*](#F8){ref-type="fig"}).

![BHA feeding improves glucose homeostasis in *Akita* mice. Wild-type and heterozygous *Akita+* male littermate mice 10--20 weeks of age were fed control chow or BHA-supplemented chow for up to 36 weeks. *A*: Blood glucose concentrations were measured between 9 and 10 [a.m.]{.smallcaps} ad libitum (*n* = 3 or 4 mice per group). *B*: GTTs were performed before and 8 weeks after feeding control chow or BHA-supplemented chow. Glucose (1 g/kg body weight) was administered intraperitoneally to mice fasted for 5--6 h (*n* = 3 or 4 mice per group). *C*: Model depicting β-cell demise caused by ER protein misfolding, subsequent ROS production, and interventions demonstrated to preserve β-cell function. All data are mean ± SEM. *\*\*P* \< 0.01.](db141357f8){#F8}

Discussion {#s19}
==========

In this study, we showed that deletion of the ER co-chaperone protein P58^IPK^ causes β-cell failure through ER stress-- and oxidative stress--mediated cell death. *P58^IPK−/−^* mice become hyperglycemic with reduced glucose tolerance as a result of decreased islet mass and β-cell insulin content and granules. At the ultrastructural level, the defect in chaperone function disrupted intracellular architecture, including distension of the ER and mitochondria. We demonstrated that *Chop* deletion, treatment with the chemical chaperone PBA, and antioxidant BHA feeding all improve β-cell function and mass in *P58^IPK−/−^*mice, indicating that *P58^IPK^* deletion causes β-cell failure because of protein misfolding in the ER and oxidative stress.

One of the unique features of pancreatic β-cells is their relatively low expression and the activity of several antioxidant enzymes ([@B39]). The expression of catalase and glutathione peroxidase is ∼5%, and that of superoxide dismutase is ∼30%, compared with the amount of liver ([@B40]). As a consequence, β-cells are susceptible to oxidative stress. Indeed, antioxidant treatment improved β-cell function in immortalized cell lines and isolated islets ([@B41]), as well as in rodent ([@B37],[@B42]--[@B44]) and human ([@B45]) islets in vivo. Here we demonstrated that antioxidant feeding prevents β-cell failure and even restores ER function in β-cells that have a primary chaperone defect that would disrupt protein folding in the ER, adding further support to the notion that protein misfolding in the ER causes oxidative stress.

A fundamental question is where the ROS are generated in β-cells during the progression to T2D. Several reports have demonstrated an association between protein misfolding in the ER and ROS production. An increase in protein synthesis was sufficient to cause protein misfolding in the ER and oxidative stress ([@B15],[@B16],[@B33]). In addition, expression of *Akita* mutant proinsulin ([@B38]; see also the results reported here), high urokinase expression ([@B46]), and expression of clotting factor VIII that is prone to misfolding ([@B31]) also caused oxidative stress. Although mechanisms have been proposed, including cysteine oxidation during disulfide bond formation to transfer electrons to molecular oxygen to produce H~2~O~2~ ([@B47]), induction of NADPH oxidase ([@B48]), and mitochondrial dysfunction ([@B49]), this is a poorly studied subject ([@B34]). Our results indicate that a primary defect in the ER protein-folding machinery is sufficient to initiate ROS production, resulting in β-cell failure typical of that observed in T2D ([@B50]), which could be rescued by antioxidant treatment ([Fig. 8*C*](#F8){ref-type="fig"}). In total, these findings suggest that oxidative stress and ER stress occur concomitantly and are principal factors that contribute to β-cell death during T2D.

Of all the antioxidants tested (Tiron, MnTBAP, TEMPOL, and BHA), BHA---and to a lesser extent TEMPOL---most significantly protected β-cell function. It is noteworthy that Tiron forms stable complexes with iron, suggesting the Fenton reaction may not cause β-cell toxicity. MnTBAP selectively neutralizes peroxynitrate over superoxide, suggesting peroxynitrate may not play a primary role in the β-cell failure described here. TEMPOL, which did protect *P58^IPK−/−^* islets to some extent, is a membrane-permeable superoxide scavenger. BHA most significantly improved β-cell function. BHA is a lipophilic free radical scavenger and may protect β-cells by preventing lipid peroxidation. Of all four antioxidants tested, BHA and TEMPOL are more related structurally. Further studies are required to characterize the unique ability of BHA to preserve the function of β-cells that have *P58^IPK^* deleted or that express misfolded mutant *Akita* proinsulin.

In conclusion, our findings show that maintenance of the protein-folding capacity of β-cells is essential to maintain β-cell function and minimize the deleterious effects of oxidative stress. Importantly, antioxidant feeding can preserve cell function in the absence of an ER protein chaperone. Therefore antioxidant or chemical chaperone treatments may provide a promising therapeutic approach for T2D.

This article contains Supplementary Data online at <http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db14-1357/-/DC1>.
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